Full Breakdown
FDA Warns of Life-Threatening Infections Linked to Recalled Nasal Sprays
12/17/2025, 9:02:22 PM
Expanded Recall of Contaminated Products
MediNatura New Mexico, Inc. has expanded its recall of homeopathic nasal sprays, specifically ReBoost and ClearLife, due to microbial contamination. The U.S. Food and Drug Administration (FDA) announced that the sprays contain unsafe levels of Achromobacter bacteria, which poses a significant health risk, particularly to immunocompromised individuals. The recall now includes all lots of both nasal sprays, which were sold nationwide online and through various retailers.
Health Risks for Vulnerable Populations
The FDA has indicated that there is a "reasonable probability" that using these contaminated products could lead to life-threatening infections, especially among those with weakened immune systems, the elderly, and individuals on certain medications. While MediNatura has not reported any adverse events related to the recall, the potential for severe health consequences remains a critical concern.
Product Details and Recall Instructions
The recalled ReBoost nasal spray has the National Drug Code (NDC) number 62795-4005-9 and the Universal Product Code (UPC) 787647 10186 3. The ClearLife nasal spray is identified by NDC 62795-4006-9 and UPC 787647 10188 7. The recall encompasses all lots and expiration dates from December 2022 through December 2025. Consumers are advised to stop using the products immediately. Those who purchased directly from MediNatura can request a refund by emailing recall@medinatura.com, while retail customers should return the products to the point of purchase.
Official Statements & Responses
MediNatura stated, “There is a reasonable probability that adverse health consequences including life-threatening infections will occur with use of the product in the immunocompromised population.” The company has emphasized the importance of consumer safety and has taken steps to address the contamination issue.
Criticism & Opposition
While the recall has been initiated to protect public health, some critics argue that the homeopathic nature of these products may lead consumers to underestimate the risks associated with their use. The lack of immediate reports of adverse events has also raised questions about the effectiveness of current regulatory measures in preventing such contamination issues.
What's Next
As the recall unfolds, MediNatura is expected to conduct further investigations into the contamination sources and implement measures to prevent future occurrences. The FDA will likely monitor the situation closely to ensure compliance and protect consumer health.
Verbatim Quotes
- “There is a reasonable probability that adverse health consequences including life-threatening infections will occur with use of the product in the immunocompromised population,” — MediNatura New Mexico, Inc.
